(Q36711509)

15 August 2017

1 reference

title

Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses (English)

1 reference

15 August 2017

2

Brogden RN

1 reference

15 August 2017

Monk JP

1

1 reference

15 August 2017

1 October 1991

1 reference

15 August 2017

1 reference

15 August 2017

42

1 reference

15 August 2017

4

1 reference

15 August 2017

659-672

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199142040-00008

15 August 2017

0 references

cites work

Allergic contact dermatitis to naftifine. Report of two cases

1 reference

12 December 2020

In vitro and in vivo cutaneous penetration and antifungal activity of naftifine.

1 reference

12 December 2020

Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents

1 reference

12 December 2020

Evaluation of fungicidal action in vitro and in a skin model considering the influence of penetration kinetics of various standard antimycotics

1 reference

12 December 2020

Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis

1 reference

12 December 2020

Naftifine solution (1%) in the treatment of pityriasis versicolor in Zambia.

1 reference

12 December 2020

Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes

1 reference

12 December 2020

The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis

1 reference

12 December 2020

The interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liver

1 reference

12 December 2020

Naftifine cream in the treatment of cutaneous candidiasis

1 reference

12 December 2020

In-vitro studies with SF 86-327, a new orally active allylamine derivative.

1 reference

12 December 2020

Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans

1 reference

12 December 2020

Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis

1 reference

12 December 2020

Morphological Changes Induced by Naftifine, a New Antifungal Agent, in Trichophyton mentagrophytes

1 reference

12 December 2020

Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis

1 reference

12 December 2020

Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group

1 reference

12 December 2020

In vitro activity of naftifine, a new antifungal agent

1 reference

12 December 2020

Antimycotic effect of naftifin in tinea pedis. Comparative double-blind study with bifonazole

1 reference

12 December 2020

[Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)]

1 reference

12 December 2020

Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group

1 reference

12 December 2020

Double-blind randomized comparative study of naftifine cream and clotrimazole cream in the treatment of dermatophytosis

1 reference

12 December 2020

Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans

1 reference

12 December 2020

In vitro action of a new antifungal agent, naftifine, on dermatophytes

1 reference

12 December 2020

In vivo antimycotic activity of naftifine

1 reference

12 December 2020

The effects of naftifine on the ultrastructure of Candida parapsilosis: a freeze fracture study

1 reference

12 December 2020

In vitro antifungal activity of naftifine: (SN 105-843 GEL) against dermatophytes

1 reference

12 December 2020

Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation

1 reference

12 December 2020

Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis

1 reference

12 December 2020

Contact allergy to the antifungal agent naftifin

1 reference

12 December 2020

Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent

1 reference

12 December 2020

Major routes of naftifine biotransformation in laboratory animals and man.

1 reference

12 December 2020

10.2165/00003495-199142040-00008

Identifiers

DOI

1 reference

PubMed ID

1723367

Dimensions Publication ID

15 August 2017

0 references

1 reference

PubMed ID

1723367